Skip to main content

We narrowed to 560 results for: Fap;

Showing: 301 - 320 of 560 results
  1. pBR25 CFAP36 [L438E, K442E, A493E, K495A]-3C-mStayGold-2Strep crBSDr (C. reinhardtii)

    Plasmid
    #238229
    Purpose
    CRISPR donor plasmid for C-terminal tagging and knock-in of CFAP36 [L438E, K442E, A493E, K495A], and insertion of Blasticidin resistance (C. reinhardtii)
    Depositor
    Insert
    CFAP36 [L438E, K442E, A493E, K495A]
    Use
    CRISPR; Donor
    Tags
    -3C-mStayGold-2Strep
    Available Since
    Feb. 2, 2026
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV.GFAP.Cre.WPRE.hGH (AAV5)

    Viral Prep
    #105550-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.GFAP.Cre.WPRE.hGH (#105550). In addition to the viral particles, you will also receive purified pAAV.GFAP.Cre.WPRE.hGH plasmid DNA. GFAP-driven Cre expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    July 26, 2018
    Availability
    Academic Institutions and Nonprofits only
  3. pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 (AAV9)

    Viral Prep
    #98930-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 (#98930). In addition to the viral particles, you will also receive purified pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 plasmid DNA. GFAP-driven glutamate sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    April 13, 2018
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV.GFAP.eGFP.WPRE.hGH (AAV5)

    Viral Prep
    #105549-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.GFAP.eGFP.WPRE.hGH (#105549). In addition to the viral particles, you will also receive purified pAAV.GFAP.eGFP.WPRE.hGH plasmid DNA. GFAP-driven GFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    EGFP
    Available Since
    April 6, 2018
    Availability
    Academic Institutions and Nonprofits only
  5. pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 (AAV5)

    Viral Prep
    #98930-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 (#98930). In addition to the viral particles, you will also receive purified pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 plasmid DNA. GFAP-driven glutamate sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    Feb. 27, 2018
    Availability
    Academic Institutions and Nonprofits only
  6. pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 (AAV1)

    Viral Prep
    #98930-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 (#98930). In addition to the viral particles, you will also receive purified pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 plasmid DNA. GFAP-driven glutamate sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    March 15, 2018
    Availability
    Academic Institutions and Nonprofits only
  7. pAAV.GFAP.Cre.WPRE.hGH (AAV PHP.eB)

    Viral Prep
    #105550-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV.GFAP.Cre.WPRE.hGH (#105550). In addition to the viral particles, you will also receive purified pAAV.GFAP.Cre.WPRE.hGH plasmid DNA. GFAP-driven expression of Cre. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    July 28, 2020
    Availability
    Academic Institutions and Nonprofits only
  8. pAAV.GFAP.SF-iGluSnFR.A184S (AAV1)

    Viral Prep
    #106192-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV.GFAP.SF-iGluSnFR.A184S (#106192). In addition to the viral particles, you will also receive purified pAAV.GFAP.SF-iGluSnFR.A184S plasmid DNA. GFAP-driven expression of SF-iGluSnFR.A184S. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    Sept. 11, 2020
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV-GFAP104-mCherry (AAV5)

    Viral Prep
    #58909-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-GFAP104-mCherry (#58909). In addition to the viral particles, you will also receive purified pAAV-GFAP104-mCherry plasmid DNA. GFAP104-driven mCherry expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    mCherry
    Available Since
    Feb. 27, 2019
    Availability
    Academic Institutions and Nonprofits only
  10. pAAV-GFAP-hM3D(Gq)-mCherry (AAV5)

    Viral Prep
    #50478-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-GFAP-hM3D(Gq)-mCherry (#50478). In addition to the viral particles, you will also receive purified pAAV-GFAP-hM3D(Gq)-mCherry plasmid DNA. GFAP-driven hM4D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    mCherry
    Available Since
    June 19, 2018
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV-GFAP-hM4D(Gi)-mCherry (AAV5)

    Viral Prep
    #50479-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-GFAP-hM4D(Gi)-mCherry (#50479). In addition to the viral particles, you will also receive purified pAAV-GFAP-hM4D(Gi)-mCherry plasmid DNA. GFAP-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal silencing. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    mCherry
    Available Since
    June 8, 2018
    Availability
    Academic Institutions and Nonprofits only
  12. pAAV-GFAP104-ChR2-mCherry (AAV5)

    Viral Prep
    #58892-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-GFAP104-ChR2-mCherry (#58892). In addition to the viral particles, you will also receive purified pAAV-GFAP104-ChR2-mCherry plasmid DNA. GFAP -driven, expression of humanized ChR2 H134R mutant fused to mCherry, for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP104
    Available Since
    Jan. 14, 2026
    Availability
    Academic Institutions and Nonprofits only
  13. pAAV-GFAP-HA-rM3D(Gs)-IRES-mCitrine (AAV5)

    Viral Prep
    #50472-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-GFAP-HA-rM3D(Gs)-IRES-mCitrine (#50472). In addition to the viral particles, you will also receive purified pAAV-GFAP-HA-rM3D(Gs)-IRES-mCitrine plasmid DNA. GFAP-driven HA-tagged rM3D(Gs) and bicistronic mCitrine expression, for chemogenetic excitation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    mCitrine
    Available Since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  14. pGP-AAV-GFAP-iGABASnFR2-WPRE (AAV5)

    Viral Prep
    #218871-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pGP-AAV-GFAP-iGABASnFR2-WPRE (#218871). In addition to the viral particles, you will also receive purified pGP-AAV-GFAP-iGABASnFR2-WPRE plasmid DNA. GFAP-driven expression of the improved GABA sensor iGABASnFR2 (positive change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  15. pGP-AAV-GFAP-iGABASnFR2-WPRE (AAV1)

    Viral Prep
    #218871-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pGP-AAV-GFAP-iGABASnFR2-WPRE (#218871). In addition to the viral particles, you will also receive purified pGP-AAV-GFAP-iGABASnFR2-WPRE plasmid DNA. GFAP-driven expression of the improved GABA sensor iGABASnFR2 (positive change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  16. pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (AAV5)

    Viral Prep
    #218873-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (#218873). In addition to the viral particles, you will also receive purified pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE plasmid DNA. GFAP-driven expression of the improved GABA sensor control iGABASnFR2(no bind) (no change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  17. pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (AAV1)

    Viral Prep
    #218873-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (#218873). In addition to the viral particles, you will also receive purified pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE plasmid DNA. GFAP-driven expression of the improved GABA sensor control iGABASnFR2(no bind) (no change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  18. pcDNA3.1-kappa-myc-dK-2xG4S-TMst

    Plasmid
    #145766
    Purpose
    Expresses myc-dL5(E52K, L91S) low affinity Fluorogen Activating Protein (FAP) on the extracellular surface anchored to the mammalian cell plasma membrane with the PDGFR transmembrane domain.
    Depositor
    Insert
    kappa-myc-dK-2xG4S-TMst
    Expression
    Mammalian
    Mutation
    The dK FAP is dL5 with mutations at E50K, L89S, a…
    Promoter
    CMV
    Available Since
    Jan. 28, 2022
    Availability
    Academic Institutions and Nonprofits only
Showing: 301 - 320 of 560 results